Bristol-Myers
Squibb Company (NYSE:BMY) today announced that Brian
Daniels, senior vice president, Global Development and Medical
Affairs, will be retiring from the company, effective July 1, 2014.
Dr. Daniels joined Bristol-Myers Squibb in 2000 and has held his current
position as senior vice president, Global Development and Medical
Affairs since 2008, leading the development of numerous innovative
medicines such as Eliquis
and Yervoy
that address serious diseases and communicating the value of these
medicines to society to ensure their safe and appropriate use.
“Brian has played a key leadership role in the success of the company’s
R&D organization and our ability to deliver innovative medicines to
patients with serious diseases," said Francis
Cuss, executive vice president and chief scientific officer,
Bristol-Myers Squibb. "He has been a champion of the patients we serve,
and I want to sincerely thank him for his loyalty and dedication to
Bristol-Myers Squibb."
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
Copyright Business Wire 2014